{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:42:43Z","timestamp":1778499763596,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.regpep.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T15:16:24Z","timestamp":1346944584000},"page":"77-83","source":"Crossref","is-referenced-by-count":56,"title":["Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects"],"prefix":"10.1016","volume":"179","author":[{"given":"Jutta","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai San","family":"Tham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamsin","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Mace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle","family":"Linnebjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2012.08.005_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","article-title":"Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus","volume":"62","author":"Kolterman","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.regpep.2012.08.005_bb0010","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.clinthera.2007.11.006","article-title":"Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial","volume":"29","author":"Barnett","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.regpep.2012.08.005_bb0015","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30weeks in sulfonylurea-treated patients with type 2 diabetes","volume":"27","author":"Buse","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.08.005_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00125-006-0510-2","article-title":"A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study","volume":"50","author":"Nauck","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2012.08.005_bb0025","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1152\/ajpendo.2001.281.1.E155","article-title":"Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers","volume":"281","author":"Edwards","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.08.005_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.005_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079908X253870","article-title":"Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3years","volume":"24","author":"Klonoff","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.regpep.2012.08.005_bb0040","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","article-title":"Effects of exenatide (exendin-4) on glycemic control and weight over 30weeks in metformin-treated patients with type 2 diabetes","volume":"28","author":"DeFronzo","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.08.005_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/jc.2009-1503","article-title":"Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia","volume":"95","author":"Deane","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.08.005_bb0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2982.2007.01079.x","article-title":"GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome","volume":"20","author":"Hellstr\u00f6m","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2012.08.005_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","article-title":"Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes","volume":"151","author":"Linnebjerg","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2012.08.005_bb0060","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","author":"Nauck","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.08.005_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1748-1716.2010.02150.x","article-title":"GLP-1 playing the role of a gut regulatory compound","volume":"201","author":"Hellstr\u00f6m","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.regpep.2012.08.005_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jcu.1870080603","article-title":"Ultrasonic evaluation of the pancreatic duct","volume":"8","author":"Parulekar","year":"1980","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.regpep.2012.08.005_bb0070","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2214\/ajr.145.5.1009","article-title":"Sonographic measurement of gallbladder volume","volume":"145","author":"Dodds","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.regpep.2012.08.005_bb0075","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.7863\/jum.2009.28.9.1143","article-title":"Comparison of sonography and scintigraphy in the evaluation of gallbladder functional studies with cholecystokinin","volume":"28","author":"Barr","year":"2009","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.regpep.2012.08.005_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiology.204.1.9205230","article-title":"Acalculous gallbladder disease: US evaluation after slow-infusion cholecystokinin stimulation in symptomatic and asymptomatic adults","volume":"204","author":"Barr","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.regpep.2012.08.005_bb0085","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1023\/A:1026678925120","article-title":"Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms","volume":"43","author":"Tolessa","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2012.08.005_bb0090","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1172\/JCI942","article-title":"Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin","volume":"102","author":"Tolessa","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2012.08.005_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.peptides.2010.09.028","article-title":"Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice","volume":"32","author":"Rotondo","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2012.08.005_bb0100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/BF01299813","article-title":"Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying","volume":"31","author":"Gullo","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2012.08.005_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10606820213687","article-title":"Structure\u2013function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors","volume":"8","author":"Brubaker","year":"2002","journal-title":"Receptors Channels"},{"key":"10.1016\/j.regpep.2012.08.005_bb0110","first-page":"1232","article-title":"Gallbladder motility in healthy volunteers: effects of age, gender, body mass index, and hair color","volume":"50","author":"Lock","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.regpep.2012.08.005_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02208580","article-title":"Relationship between gastric and gallbladder emptying and refilling in normal subjects and patients with H. pylori-positive and -negative idiopathic dyspepsia and correlation with symptoms","volume":"41","author":"Marzio","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2012.08.005_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/RUQ.0b013e3181e17516","article-title":"Ultrasound of the extrahepatic bile duct: issues of size","volume":"26","author":"Horrow","year":"2010","journal-title":"Ultrasound Q"},{"key":"10.1016\/j.regpep.2012.08.005_bb0130","author":"European Medicines Agency"},{"key":"10.1016\/j.regpep.2012.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1177\/0091270008323750","article-title":"Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus","volume":"48","author":"Kothare","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.regpep.2012.08.005_bb0140","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1210\/jc.2002-021545","article-title":"Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes","volume":"88","author":"Kolterman","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.08.005_bb0150","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5414\/CP201462","article-title":"A thorough QT study to evaluate the effects of singledose exenatide 10\u03bcg on cardiac repolarization in healthy subjects","volume":"49","author":"Linnebjerg","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.regpep.2012.08.005_bb0155","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2337\/diabetes.53.9.2397","article-title":"Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia","volume":"53","author":"Degn","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.08.005_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2337\/diacare.24.2.371","article-title":"Relationships of upper gastrointestinal motor and sensory function with glycemic control","volume":"24","author":"Rayner","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.08.005_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0091270010367653","article-title":"Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers","volume":"51","author":"Pinelli","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.regpep.2012.08.005_bb0170","article-title":"Clinical pharmacokinetics of exenatide in patients with type 2 diabetes","volume":"7","author":"Reddy","year":"2005","journal-title":"AAPS J"},{"issue":"Suppl. 3","key":"10.1016\/j.regpep.2012.08.005_bb0175","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S1590-8658(03)00087-2","article-title":"Gallbladder motility in obesity, diabetes mellitus and coeliac disease","volume":"35","author":"Fraquelli","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.regpep.2012.08.005_bb0180","first-page":"2391","article-title":"Gallbladder motility in diabetes mellitus using real time ultrasonography","volume":"91","author":"Hahm","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.regpep.2012.08.005_bb0185","first-page":"73","article-title":"Real-time sonography for screening of gallbladder motility in diabetic patients: relation to autonomic and peripheral neuropathy","volume":"24","author":"Kayacetin","year":"2003","journal-title":"Neuro Endocrinol Lett"},{"issue":"Suppl. 2","key":"10.1016\/j.regpep.2012.08.005_bb0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2036.2000.014s2062.x","article-title":"Review article: gall-bladder motor function in diabetes mellitus","volume":"14","author":"Pazzi","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.regpep.2012.08.005_bb0195","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","article-title":"Gallstone disease: epidemiology of gallbladder stone disease","volume":"20","author":"Shaffer","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T14:20:42Z","timestamp":1562163642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011512002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":38,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0167011512002212"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2012.08.005","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}